ATE352544T1 - Verfahren zur herstellung von imidazolderivaten und deren salzen - Google Patents

Verfahren zur herstellung von imidazolderivaten und deren salzen

Info

Publication number
ATE352544T1
ATE352544T1 AT03703511T AT03703511T ATE352544T1 AT E352544 T1 ATE352544 T1 AT E352544T1 AT 03703511 T AT03703511 T AT 03703511T AT 03703511 T AT03703511 T AT 03703511T AT E352544 T1 ATE352544 T1 AT E352544T1
Authority
AT
Austria
Prior art keywords
salts
imidazole derivatives
producing imidazole
producing
salt
Prior art date
Application number
AT03703511T
Other languages
English (en)
Inventor
Jeong-Seok Chae
Tai-Au Lee
Sang-Seon Park
Doo-Byung Lee
Beom-Joo Maeng
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Application granted granted Critical
Publication of ATE352544T1 publication Critical patent/ATE352544T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT03703511T 2002-02-08 2003-02-06 Verfahren zur herstellung von imidazolderivaten und deren salzen ATE352544T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0007231A KR100432577B1 (ko) 2002-02-08 2002-02-08 이미다졸 유도체의 제조방법

Publications (1)

Publication Number Publication Date
ATE352544T1 true ATE352544T1 (de) 2007-02-15

Family

ID=27656413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03703511T ATE352544T1 (de) 2002-02-08 2003-02-06 Verfahren zur herstellung von imidazolderivaten und deren salzen

Country Status (9)

Country Link
US (1) US6706888B2 (de)
EP (1) EP1472232B1 (de)
JP (1) JP4201268B2 (de)
KR (1) KR100432577B1 (de)
AT (1) ATE352544T1 (de)
AU (1) AU2003206243A1 (de)
DE (1) DE60311425T2 (de)
ES (1) ES2279093T3 (de)
WO (1) WO2003066600A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11897915B2 (en) 2021-09-13 2024-02-13 Rubedo Life Sciences, Inc. Sugar derivatives and uses thereof to prepare novel senolytic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CA2238081A1 (en) * 1995-11-22 1997-05-29 S. Jane Desolms Inhibitors of farnesyl-protein transferase
US5932590A (en) 1996-12-05 1999-08-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP1035849A4 (de) 1997-12-04 2001-09-12 Merck & Co Inc Farnesyl-protein transferase inhibitoren
US6133291A (en) 1998-10-16 2000-10-17 Schering Corporation N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
US6211182B1 (en) * 1999-03-08 2001-04-03 Schering Corporation Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
KR20010011698A (ko) 1999-07-30 2001-02-15 김선진 라스 변이세포의 성장을 억제하는 티오우레아 유도체 또는 이들의 무독성염
KR20010076862A (ko) * 2000-01-28 2001-08-16 성재갑 1-치환된-2-머캅토-5-히드록시메틸 이미다졸의 제조방법

Also Published As

Publication number Publication date
EP1472232A4 (de) 2006-02-01
EP1472232B1 (de) 2007-01-24
JP2005523272A (ja) 2005-08-04
US6706888B2 (en) 2004-03-16
EP1472232A1 (de) 2004-11-03
JP4201268B2 (ja) 2008-12-24
DE60311425T2 (de) 2007-10-31
ES2279093T3 (es) 2007-08-16
KR100432577B1 (ko) 2004-05-24
US20030153769A1 (en) 2003-08-14
DE60311425D1 (de) 2007-03-15
WO2003066600A1 (en) 2003-08-14
KR20030067784A (ko) 2003-08-19
AU2003206243A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
ATE501126T1 (de) Verfahren zur herstellung von rosuvastatin
ATE406387T1 (de) Verfahren zur herstellung von hydroxyalkylstärkederivaten
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DE60336326D1 (de) Verfahren zur herstellung des calciumsalzes von rosuvastatin
DE60328492D1 (de) Verfahren zur erzeugung von nanoteilchen
UA86041C2 (uk) Сульфоксімінзаміщені піримідини як інгібітори cdk та/або vegf, їх одержання та застосування як лікарських засобів
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
RS20060250A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, method for the production thereof, and their use as antiphlogistics
DE502004004681D1 (de) Verfahren zur herstellung von salzen schwach koordinierender aniomen, derartige salze sowie deren verwendung
ATE521587T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1- diethylaminocarbonyl-2- aminomethylcyclopropanhydrochlorid
ATE537173T1 (de) Verfahren zur herstellung von cucurbiturilen
ATE374755T1 (de) Verfahren zur herstellung von 1,3,5- triazincarbamaten und -harnstoffen
ATE516290T1 (de) Verfahren zur herstellung von buprenorphin und derivaten von buprenorphin
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
ATE476426T1 (de) Verfahren zur herstellung von alkoxycarbonylamino-triazinen
ATE525364T1 (de) Verfahren zur herstellung von 3,6-dihydro-1,3,5- triazin-derivaten
ATE352544T1 (de) Verfahren zur herstellung von imidazolderivaten und deren salzen
ATE348811T1 (de) Verfahren zur herstellung von 2- aminomethylpyridin-derivaten
ATE431076T1 (de) Verfahren zur herstellung von imidazolverbindungen und salzen und deren pseudopolymorphen
ATE386734T1 (de) Verfahren zur herstellung von (4-hydroxy-6-oxo- tetrahydropyran-2-yl) acetonitril und dessen derivaten
ATE493423T1 (de) Verfahren zur steuerung der kristallstruktur von risedronat
ATE447563T1 (de) Verfahren zur herstellung eines immunosuppresivums
ATE546432T1 (de) Verfahren zur herstellung von 2- aminomethylpyridin-derivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties